Dr. Subodh Chandra Pande

MBBS, MD (Radiotherapy)

Chief – Radiation Oncology

36+ Years of Experience
Gurgaon

Dr. Subodh Chandra Pande is a distinguished senior figure and a premier global authority in radiation oncology. With over three and a half decades of high-volume clinical and academic experience, Dr. Pande has been instrumental in establishing modern radiation oncology facilities at premier institutions across India, including the Tata Memorial Hospital (Mumbai) and the Indraprastha Apollo Hospital (New Delhi). He represents the absolute peak tier of technological competence, specializing in stereotactic radiosurgery and complex pediatric radiation setups. Known for his deeply intellectual mind and meticulous treatment planning, he ensures international-standard safety across all radiation fields.

  • Stereotactic Radiosurgery (SRS) & SRT: Pinhole, ultra-high-dose radiation delivery targeting deep cranial lesions, acoustic neuromas, and brain metastases.
  • Stereotactic Body Radiotherapy (SBRT): Delivering precise, high-dose radiation over few fractions to early-stage lung, liver, and prostate tumors.
  • Pediatric Radiation Oncology: Specialized, low-dose-contoured radiation lines configured specifically to protect developing tissues in children.
  • Intensity Modulated Radiation Therapy (IMRT/VMAT): Advanced volumetric arc tracking to shape radiation precisely around complex head, neck, and pelvic tumors.
  • Successfully planned and managed radiation courses for tens of thousands of cancer patients across India’s top oncology setups.
  • Played a monumental role in introducing and popularizing image-guided brachytherapy and respiratory gating protocols in North India.
  • Prominent academic mentor who has trained a generation of practicing radiation oncologists and served on multiple national oncology advisory boards.
  • Conferred with prestigious Lifetime Achievement awards and corporate clinical leadership honors at major oncology symposia.
  • Active senior member of the Association of Radiation Oncologists of India (AROI) and the American Society for Radiation Oncology (ASTRO).